Synlico Inc.

Synlico Inc. is a resident company of Johnson & Johnson Innovation – JLABS, a premier life science incubator program. Synlico is at the forefront of transforming biology by leveraging causality to make cellular processes explainable, predictable, and engineerable. Our focus is on developing innovative therapies for oncology and other diseases by employing the latest development in artificial intelligence, causal discovery & inference, and single-cell bioinformatics. Our unique approach lies in unraveling the causal relationships between cells' intracellular activities and their responses in the patients’ heterogeneous microenvironment, predicting how cell modulation alters its behavior in patients. Synlico leverages a causal- and prediction-based approach to navigate the complexities/heterogeneity of diseases.